Google TrendARSENAL (5000+) — Arsenal v Lille: Champions League – live
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "A real-world propensity a" (30 stories)

Top Headline Story

Resmetirom Tied to Lower MACE vs Semaglutide in Real-World MASLD Analysis
Lead StoryHCPLiveworld
1d ago

Resmetirom Tied to Lower MACE vs Semaglutide in Real-World MASLD Analysis

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQUHpJOXdkcFE2bnA0cUxZY0p0eDFsV0x4UlhTMWxaWlpXUHROMXlZbWJUdUpkc0FuZjkwWlo1WjFyWkJZS2JNRFhnM0laY1lqRTQzRUxKempMWXFKMU5RSThmTFVnbGhNMjgzTEV1NmZjSkNKclJZNHQ5azMtSjBhSTNzVTJQRDBMdlBYV0h0WU1ZRzNHREVhOVNkM0NYMWhmRnZQWQ?oc=5" target="_blank">Resmetirom Tied to Lower MACE vs Semaglutide in Real-World MASLD Analysis</a>  <font color="#6f6f6f">HCPLive</font>

Real-time search volume
5000+19m ago

arsenal

Arsenal v Lille: Champions League – live

500+19m ago

anthony gordon

Anthony Gordon's first Barcelona goal, Manuel Neuer's mistake and Djed Spence's Inter debut in the Euro Debrief

2000+29m ago

montez sweat

Bears DE Montez Sweat suspended two games for violating NFL's PED policy

1000+39m ago

rob lowe

Ben Shapiro’s Star-Studded ‘Confession’ Film Includes James Franco, Rob Lowe And More

Search Results for "A real-world propensity a"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Standalone Middle Meningeal Artery Embolization Versus Surgical Evacuation for Nontraumatic Subdural Hematoma: A Propensity-Matched Multicenter Real-World Study
Cureusworld

Standalone Middle Meningeal Artery Embolization Versus Surgical Evacuation for Nontraumatic Subdural Hematoma: A Propensity-Matched Multicenter Real-World Study

<a href="https://news.google.com/rss/articles/CBMipAJBVV95cUxPa1dTaERock5oZzFJenE4SENEcnRSOGhLZXdvTk5ZZHI5SVlEMUlPcHYzT2pOUEhyZVBwRUp2UHlrNFdkZ1VTanc3aGNBd0xqVjk3V1NjVUpxTGhUazhYT3R1LUZGNmNjWWNGbmM1ZUVTQWZ0NURzb1ZnREl3eDFIZFhaclpaR2FCQjkweGF3UElBQVlmamVsWU1kTXg3OElCUWZVNFlNai12UmJaNFNpbFNzUjJTOUljWG53RFNlS3lIQktrSEYydllKS3NCczRkQ3ZEVmdzaDB6UWFLRTNSN256R1N0cTB3VGl4RWVHZ2x1OEZOb3dNczA2eTlxSUs5LUFHWEpuNDJCLUVIOXRjOGZHSzJVZmFaUDJEZ2VjQXVKcl9z?oc=5" target="_blank">Standalone Middle Meningeal Artery Embolization Versus Surgical Evacuation for Nontraumatic Subdural Hematoma: A Propensity-Matched Multicenter Real-World Study</a>  <font color="#6f6f6f">Cureus</font>

GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease and obesity: a propensity score–matched real-world cohort study
Natureworld

GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease and obesity: a propensity score–matched real-world cohort study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB6b2ZycU11dU9FSl9kRlRiX0cwTGkweWtVdWNSaFRIVzZKUjExOTBTS052VHVPMXVoUE5yWXhtM2paSWR6SERmZ3dVMFFPQ1Jsc0t5d1p2cmpsbmZHeFo4?oc=5" target="_blank">GLP-1 receptor agonists and clinical outcomes in adults with Crohn’s disease and obesity: a propensity score–matched real-world cohort study</a>  <font color="#6f6f6f">Nature</font>

A GLP-1 bone study shows why matching matters in real-world evidence
Drug Discovery & Developmentworld

A GLP-1 bone study shows why matching matters in real-world evidence

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNR0IwWTBfdjhqbXR1MDZTWEd2VkNIVFhMYnFTN0FYX0x1YUxlMjhJUnQ1ZmVQcnRoNDhOLVo3ZUJFT2pBLUdmdE5hZ1BoempncVpIbDhnbHlhQ21rQUVOcGhkNk9LZlNFbk5RVl8yOFBPTmkzWFNlbnhZb3JPWXZ5LUVPUm96WEdHNG5Ha3p3WkZma1pETEpSdGhHUDh6blZjVnF5VGxpTUE?oc=5" target="_blank">A GLP-1 bone study shows why matching matters in real-world evidence</a>  <font color="#6f6f6f">Drug Discovery & Development</font>

A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction
Natureworld

A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBCdVRobEd2MkctbDQ5ZFpLdXRtUERjWTFCY0VaakhmbGdVaFlxMEdfaE9POTlfTWF5X2p3SVVFaWluVzlMdlAxdmVwT2hvR3FSX0pwQk9fQlBqZF9Yd3U4?oc=5" target="_blank">A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction</a>  <font color="#6f6f6f">Nature</font>

Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL
AJMCgeneral

Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOOUVmUkprMndhNnlCcHY5ZHMybV9Bel9oTWZrb1lhZjhmcmQ3Y1JhREwwOTdyMVE0QkdVNUJMY2RxYWFhLWFWenAtbnNFbmNoR19aeUZoU2lOVmdVQnJvY1Y5MXUyemt4d0JBZDVjYlVZZzhZM2pZRm9uTUs2MFJyNDlNTlFmN3hNRXkwU2Z5OA?oc=5" target="_blank">Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL</a>  <font color="#6f6f6f">AJMC</font>

Addition of Bupropion or Varenicline to Nicotine Replacement Therapy After Acute Coronary Syndrome: A Propensity-Matched Real-World Analysis
medRxivworld

Addition of Bupropion or Varenicline to Nicotine Replacement Therapy After Acute Coronary Syndrome: A Propensity-Matched Real-World Analysis

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTFA4LXlmY1drUFRLbE5BUEUtQzZTUU96YU9UZ3g2dV8zc0tjUUNOZHNRSDhYdXN1NTBGMmdFbVFLcGlnYkItZmV1ZXNTWnBHWnlqaVpxRUphRW9WQ25WcXplZWdhdEplMFczQmpjUmNBdS1paXpac05McnV5S1k?oc=5" target="_blank">Addition of Bupropion or Varenicline to Nicotine Replacement Therapy After Acute Coronary Syndrome: A Propensity-Matched Real-World Analysis</a>  <font color="#6f6f6f">medRxiv</font>

GLP-1 Receptor Agonists Reduce Cardiac Dysfunction in Cancer
European Medical Journalworld

GLP-1 Receptor Agonists Reduce Cardiac Dysfunction in Cancer

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQTXQ5SjhHbnNJUXpYM0VoalJaSE94ZzlGN001cUhuVDhYdk1PSkg4c3BPbi1nemZqRXlHX0dmaHZWMWIzSjFLRmtkbGxmTktibEp2SHZfTVptT2gtdjRvMHJPRXhqWXZrV3Fjc1dwMTdFM1lLZFRCU0lNVHo3ODhxNHRyZWxUMl9ySDNlbU1GLVBxVWdtQ29aVzd6Wi1RVDFFM0ZBZVlUVQ?oc=5" target="_blank">GLP-1 Receptor Agonists Reduce Cardiac Dysfunction in Cancer</a>  <font color="#6f6f6f">European Medical Journal</font>

GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research
Oncology Nursing Newsgeneral

GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNRk5FLW1ZQmdHZXJoZXpHdnBqOXJnTWs3TVhQUmVIREhOMUNPczNIRlpUS0NxQWJXZ2YyNHM2R0wwV3F0RzlnQ0ZMTEJKZTRhaTYtQ0thcVVDNktpR0p1Y2tPSXJGbWNYdlI4NlBXUVZWancwTFhVVkxnYWhZTU5scEgwYm5rTExtUlg0cW10c2NZRWpNWC1SbDR3?oc=5" target="_blank">GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research</a>  <font color="#6f6f6f">Oncology Nursing News</font>

Association of Tirzepatide Use With Clinical Outcomes After Transcatheter Aortic Valve Replacement in Obese Patients: A Propensity-Matched Real-World Study
HMP Global Learning Networkworld

Association of Tirzepatide Use With Clinical Outcomes After Transcatheter Aortic Valve Replacement in Obese Patients: A Propensity-Matched Real-World Study

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQYzIwVmZOeXdDNk05aWRfZkRiUDJEalRVWEh4OElBS2xhZE0xNVJRTzhWNUFJcWR5YkYzRUcycXJlQmhrVGxNd2lPSlIwQzdNLWNSS0pwWDd4U3VKbGtmV0FpbENPTVhMc3R1dmFxS01rSlBKNktMeU4zckN4TFRRNTNmeldqc0lZdlBLUmRNQ0tRdGtZeFRzZjY1dE03Uzd2T3dGWVo3WS1BVWl0dWttVWFrV01hNXRES3BPZng5QkV6d2h2MFBGNTl0R0FRcXF6?oc=5" target="_blank">Association of Tirzepatide Use With Clinical Outcomes After Transcatheter Aortic Valve Replacement in Obese Patients: A Propensity-Matched Real-World Study</a>  <font color="#6f6f6f">HMP Global Learning Network</font>

Phathom Pharmaceuticals Highlights Breadth of Independent
GlobeNewswiregeneral

Phathom Pharmaceuticals Highlights Breadth of Independent

<a href="https://news.google.com/rss/articles/CBMioAJBVV95cUxNVlVjZFVTM2xQUV8yeGxJRnZwM2NUT1ZGUHI2ZGxGbFlIYlFTR2hleUJKZWhObDlpSktMb0FMd0RLcHRXaWhUWkh4eXZPUlJKazAzbzJPTW1EU19mREY1TE5zX1oxYTQ3TlhCTV96b3haNkstc2JuanJvRFhrQmVxRmFaaW94UFZtM3RsejB1MHRPRWItS2Z2dEpIT1J6TlFPZ1BGWm5hX0ZGeVk0RG9JRUVfa056eXd3cE10dGRYaDFwbE1VRHJfdnZBSTNpQWpPSHJlLW9HSFU3a3NMeF9sNjZwLXpaa0dFYlJDeUFrNWIwNk55a2pCamItU3BmWUpoM1RtYXFYcEdkSVJGUWdoUnpmS2dBY1N5MVNHRmRlblc?oc=5" target="_blank">Phathom Pharmaceuticals Highlights Breadth of Independent</a>  <font color="#6f6f6f">GlobeNewswire</font>

Real-World Data Shows Less Afib, All-Cause Mortality With Zanubrutinib Than Ibrutinib in B-Cell Malignancies
AJMCworld

Real-World Data Shows Less Afib, All-Cause Mortality With Zanubrutinib Than Ibrutinib in B-Cell Malignancies

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQWHdsU2dvM296MkdnMnJLWk9aSlg4Q1EyOU1DTWpHZGwyZTB1d3BESnRNWWlVWkdEMENKUVRxUHRHNk4xOFlETWhtSE5NV0pwRERyVTRTVnEtd1BoUDhwN0FSZWNrUlRxaDZGU19MeW5nWmNnWWdRTTBfM3AwZm1TM1VadjFkeUJwTFZlVlo5ejZKNUpkRmxZdmxyRUc5eHd2UUtkMHdRNHRHVDU0ZEtZbXl5cGJpYXY1NGJaemF6X0dRLUhaZnIyckJVeUw3UQ?oc=5" target="_blank">Real-World Data Shows Less Afib, All-Cause Mortality With Zanubrutinib Than Ibrutinib in B-Cell Malignancies</a>  <font color="#6f6f6f">AJMC</font>

Real-World Analysis Links Empagliflozin to Lower Cardiorenal Event Risk Versus Dapagliflozin in T2D
HCPLiveworld

Real-World Analysis Links Empagliflozin to Lower Cardiorenal Event Risk Versus Dapagliflozin in T2D

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPOEVZMk9yaXhKMUpBMDBUa0RNTUpwNXJhLWVod0t6S2NxMURuVlBsdlBpNHVYQnFwdzlNbzNWN3hsTWtLWmlwUTZ5eVBtekJXUTl1bHZpaHJxYXJWZmRoa0x6M1VpVUdlam1PWi1ab0tvRWxrUHhtR2M2cDQ0WHFIQmZ5clRWcGZ4SXRGMUFJT05idHYwd3gyRWIwVG5GRU04N1lmVlNZdFZQNnpYaFdJQW5iU1QyQVBWZmxxaENKOGxrc2F0N3Vz?oc=5" target="_blank">Real-World Analysis Links Empagliflozin to Lower Cardiorenal Event Risk Versus Dapagliflozin in T2D</a>  <font color="#6f6f6f">HCPLive</font>

Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study
Wiley Online Libraryworld

Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9rMjVZbkU5NXBMM1VPYVJTVHUwbTMxclNsNjJIcGxqdms0cHBFbjZ5UFM5TE8wUnNmMVh1M1FBMm85QWRVZkJtQlpoaFNWNUoya1N4bktZejUyYUVWNGU4dm96ZmdNMzRxR3Nr?oc=5" target="_blank">Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study</a>  <font color="#6f6f6f">Wiley Online Library</font>

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says
MedPage Todayworld

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFBCS0pmRlFYdGRxcXpCUDRkYnUwVExGQ3l6NGpxYUxMb2J6cl9CUUxsNkhENHZjTVBRaUpMZ2lTaW1LYldZaG45azhMRWdvNnAzOFdwcUpydTA3dFlmVjhrQjM1VUlxb2FBRnRFOHA4U29tbnJ2?oc=5" target="_blank">Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says</a>  <font color="#6f6f6f">MedPage Today</font>

Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matching
Frontiersworld

Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matching

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPbkRfZGl2WDlidjJ2aGc5YXFWbXZiTFpCWEpPOGhFWGtmZDAtb2Q0cDZ4RjJ1aTBDMVVKN0tCU09SVDl0VVEyTmhqNG1FVlRmQm1RaEw0cTFKZ1dpaGNrQW9rQTZET2RwZjQ0M1B1Y21LZ2dIX2ljWFJESWVSV29xNkNINS1kTmZYcm0zdzJR?oc=5" target="_blank">Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matching</a>  <font color="#6f6f6f">Frontiers</font>

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes
Natureworld

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2elQ3b0E0S1ZQdFpkR1YwRmd4djhCWEJ2VncxSDNwMlhzeGFLY0R1QnVLZDlpaUFDTU5MSGxMSGNVRFJsRmc3a2RYT2RidGpzNURLbUthLVBOM1BHWmpn?oc=5" target="_blank">Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes</a>  <font color="#6f6f6f">Nature</font>

Obesity and risk of immune-mediated inflammatory diseases: a real-world propensity score-matched cohort study using electronic health records
Naturescience

Obesity and risk of immune-mediated inflammatory diseases: a real-world propensity score-matched cohort study using electronic health records

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TTHNfVGItb0VXd24tVC1mdUdIcjc1bWNNc0NBSTlqdkpiSUd3cTFlOEVmRkFlOGdkdE9JMGw1UEhMYktpQ20wa0hIdDU5dEdQNm1ZMDJYbWg2ZW96a0Vj?oc=5" target="_blank">Obesity and risk of immune-mediated inflammatory diseases: a real-world propensity score-matched cohort study using electronic health records</a>  <font color="#6f6f6f">Nature</font>

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal
Natureworld

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1ZSTNVTjJCVFduenpaNWRvYlJJSzJoRnR1WWFOWWwwclVRdjdZY1J4MGI2SnBpbnpsZ3FIVHBNUlp2VTFGYU5peXdVZEhmQkpUWE5GR3BlcjMyRkx5WElR?oc=5" target="_blank">Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study
Natureworld

Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BWGkyejU2NUhSZ3ZrQkZNV0FvWThzd1dEeExmQVBUOU5ZNDI2VUYzVmtSaHVha3VreVR0d2s2VGc2UkdEVjZHS0VIZnBIOTJ6YmNpWVg5X0RZaGFsRFVZ?oc=5" target="_blank">Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study</a>  <font color="#6f6f6f">Nature</font>

Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)
Natureworld

Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0dnJxbFh3dVJTMmhRaUJCamphbGN2ZHVoMktnWlBfNVRjX09mc2l3dkRnZ0dnTWpaTlB3a2t5VXEtaXdZTnU3Y0sxSnRHTDZJNEtGNW9Yb0tUU0Jnb1dF?oc=5" target="_blank">Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)</a>  <font color="#6f6f6f">Nature</font>

Healthcare costs after kidney transplantation compared to dialysis based on propensity score methods and real world longitudinal register data from Sweden
Naturescience

Healthcare costs after kidney transplantation compared to dialysis based on propensity score methods and real world longitudinal register data from Sweden

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5nSVZiTzZOTlpKRk9PQU5PSjJ6TEx0dlJBck9NT0F6ekVkRGhIZFJpel9JWFBya3dMelB1M1VHTW91VzREXzZGdkZqQ3FuN1BZOHlrTG9oQW5Jb2N0Zkp3?oc=5" target="_blank">Healthcare costs after kidney transplantation compared to dialysis based on propensity score methods and real world longitudinal register data from Sweden</a>  <font color="#6f6f6f">Nature</font>

A novel digital twin strategy to examine the implications of randomized clinical trials for real-world populations
Natureworld

A novel digital twin strategy to examine the implications of randomized clinical trials for real-world populations

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9RZm45M01JS2VLSGNQNWVmaFFnS1B0aVZpLThwbXNzT3lqZ05ndmZvSU15QkxKUG95UWFnT2FRNnlZd09wdU1XLUZGekdZN3V2b0J0T1ZMYU90R1pmWnpJ?oc=5" target="_blank">A novel digital twin strategy to examine the implications of randomized clinical trials for real-world populations</a>  <font color="#6f6f6f">Nature</font>

Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits
Cardiovascular Businessgeneral

Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits

<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQTUg5blRlVFFUYkdfOFI4LWlYNEJkMzhIekxnNEFJejBWbi1Bd0dIU0QyaWJiODVKZDlnRVlsWkpGUWVNRmFWVWstV1ZQUmVVcXhUNjdhR0lrR2JGdVZSNE9ldS1Zd3FqZlpRMHU0WmpxSm1Pb3U5NTFqdUNwdEVmQ0ZpMjRJLXBWZEp0Sm9md2t5cXU3UlBBd1gwVjVRZHFQM1h2WEM0TDJmbFlNbHNlbmxleFU0TFp6ZGhWdDhVUk1aRnpnVlR0TDdRUmVhdzZDYUlnaG5qSDhlaW1zRElJRFFFSQ?oc=5" target="_blank">Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Small-World Propensity and Weighted Brain Networks
Naturetech

Small-World Propensity and Weighted Brain Networks

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE8yUWRwZ25CcnFrVTlGLU5mYkREYVlGUzlQUms5c1dLQ2xzRzc3ck9YVGZ0enpsT0V2WG9jWkZFQ0Fnd3Nmc0xHdDJSVTAtOTlsUk5N?oc=5" target="_blank">Small-World Propensity and Weighted Brain Networks</a>  <font color="#6f6f6f">Nature</font>

Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience
Frontiersworld

Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPZncydXl1T0NOZGlYbVBDWHNabDJJX0c1TjRPaDhaLV9iamxRUGR1eS1sbkhGbEpsZ244ZUdSV0c2X2ZYaHJvMFUwZEtWVUJrU3ZoSXdQOUJaNW50TnN6UEhoWkpEWmhYRGdobzY5eVR3eUNSNHBSMzB0WDRXcVRoVDlzSFdxUFJRT2xXNFlkS09BQQ?oc=5" target="_blank">Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience</a>  <font color="#6f6f6f">Frontiers</font>

Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations
Natureworld

Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1uSE9tY1o1X1lod3lIV3N4ZjNfRk5QV0dhT2ZXSlRtSGpGWGk0SUo0ZnpMcFVnelVrNXh1WnRlZldvQjRiZnJsY1piNVg4ZWtBREVkQ1ZhRmEzVTJMS1dz?oc=5" target="_blank">Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations</a>  <font color="#6f6f6f">Nature</font>

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
Natureworld

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE85SzF1bDFISDQ0c0RJeE5kaWhhQUVzeDdfTWJNT0tyXzdfeFh0NGktcml2MHdUa1doQ2FIdEF2X3p4NTZZUGNXX0F0aVdwSE5PM2dkdUZSYlEtaE9KQ0Y4?oc=5" target="_blank">A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine</a>  <font color="#6f6f6f">Nature</font>

Exploring the predictive values of ABSI and BRI in premature coronary artery disease based on a real world study
Natureworld

Exploring the predictive values of ABSI and BRI in premature coronary artery disease based on a real world study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9qVUF5VEJQLXJRSE1VcTNOTUdYdFZHZ3RFdjlCTEVCZTczTVVaSDcxQUpKTm5OZHF6cGZBa3hVM0pZZFRYY3pjSmFsTVFGbW5fcGxHMDlNRGU2Vld0VG9J?oc=5" target="_blank">Exploring the predictive values of ABSI and BRI in premature coronary artery disease based on a real world study</a>  <font color="#6f6f6f">Nature</font>

Human papillomavirus infection and the risk of uveitis: a propensity-score-matched electronic health record study
Naturescience

Human papillomavirus infection and the risk of uveitis: a propensity-score-matched electronic health record study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE54aGs0OXprMFBSbTBUa1hreVh2UGQ1emQ3UjJSVVBxQmRkRHd4ZTFPQ0FhcWY1NW95ME1tNzRQN21aaUpuaVpqY2RmMGxnRnFmME1rYXNVcFJUWlcwRnpZ?oc=5" target="_blank">Human papillomavirus infection and the risk of uveitis: a propensity-score-matched electronic health record study</a>  <font color="#6f6f6f">Nature</font>

"A real-world propensity a" — Live Google News Trends & Headlines